United States· US:0009-0017_632e2836-1da3-4c6d-a954-e452580587e2
Halcion
A medicinal product containing triazolam, registered in United States by Pharmacia & Upjohn Company LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- triazolam
- Manufacturer
- Pharmacia & Upjohn Company LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 2
- ndc110009001755100 BLISTER PACK in 1 CARTON (0009-0017-55) / 1 TABLET in 1 BLISTER PACK
- ndc11000900175810 TABLET in 1 BOTTLE (0009-0017-58)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Triazolam in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayHalcionPfizer
- CanadaTRIAZOLAMAA PHARMA INC
- FinlandHalcionPfizer Oy
- IrelandHalcion 250 microgram TabletsPfizer Healthcare Ireland Unlimited Company
- SwedenHalcion 0,25 mg TablettPfizer AB
- BelgiumHalcion 0.125 mgPfizer
- GermanyHalcionPfizer Pharma Gmbh
- SpainHALCION 0,125 mg COMPRIMIDOSPfizer S.L.
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Halcion
- Belgium · Halcion
- Germany · Halcion
- Spain · Halcion
- Finland · Halcion
- Ireland · Halcion
- Italy · Halcion, Songar
- Lithuania · Halcion
- Luxembourg · Halcion
- Latvia · Halcion
- Portugal · Halcion
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/441d54fa-98ad-4097-986d-e9f645a399bc GET /v1/drugs/441d54fa-98ad-4097-986d-e9f645a399bc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 5
},
"productid": "0009-0017_632e2836-1da3-4c6d-a954-e452580587e2",
"productndc": "0009-0017",
"dosage_form": "TABLET",
"dea_schedule": "CIV",
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "TRIAZOLAM",
"proprietary_name": "Halcion",
"active_ingred_unit": "mg/1",
"application_number": "NDA017892",
"marketing_category": "NDA",
"nonproprietary_name": "triazolam",
"start_marketing_date": "19821115",
"active_numerator_strength": ".25"
}See everything about triazolam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.